Researchers at the University of Zurich have reported promising advancements in the use of stem cell transplantation as a potential treatment for stroke damage. This innovative approach aims to regenerate neurons and restore motor functions, addressing the significant residual impairments experienced by many stroke survivors. Approximately one in four adults will suffer a stroke in their lifetime, often resulting in permanent damage due to cell death from oxygen deprivation or internal bleeding, underscoring the need for new therapeutic strategies.
The studies conducted by a team led by Christian Tackenberg, along with postdoctoral researcher Rebecca Weber and collaborators from the University of Southern California, focused on neural stem cells derived from induced pluripotent stem cells. These stem cells were transplanted into mice that had undergone a stroke, closely simulating human stroke conditions. The research indicated that the transplanted stem cells not only survived for five weeks but also differentiated into new neurons and established communication with existing brain cells.
Beyond neuronal regeneration, the studies observed additional beneficial effects, including the formation of new blood vessels and a reduction in inflammatory responses. Importantly, the research suggests that timing plays a crucial role, with stem cell transplantation showing enhanced effectiveness when performed one week post-stroke.
While the findings are optimistic, Tackenberg emphasizes the necessity of further research to mitigate risks associated with stem cell therapies and to streamline their application in human patients. Current efforts include developing a safety mechanism to manage stem cell growth and exploring less invasive delivery methods. Initial clinical trials for induced stem cells targeting other conditions, such as Parkinson’s disease, are underway in Japan, hinting at the potential for similar trials for stroke in the future.